6872.TWO NaviFUS Corp.
- Market cap
- TWD 1.21B
- P/E
- -
- P/B
- 2.60x
- ROE
- -29.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6872.TWO undervalued?
Graham numberThe Graham number of NaviFUS Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NaviFUS Corp. fundamental analysis
No fundamental analysis for NaviFUS Corp. yet.
NaviFUS Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NaviFUS Corp.
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgica…
Full company profileNaviFUS Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
NaviFUS Corp. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 19.5M | 22.5M | 27.5M | 10.5M | 43.0M |
| Gross Profit | 0.00 | 16.5M | 11.8M | 9.68M | -2.79M | 21.0M |
| Operating Income | -82.6M | -72.9M | -76.4M | -111M | -160M | -159M |
| EBITDA | - | -53.8M | -55.8M | -77.0M | -123M | -117M |
| Net Income | -82.8M | -63.6M | -65.7M | -95.1M | -148M | -145M |
| EPS | -1.45 | -1.12 | -1.15 | -1.53 | -2.10 | -2.04 |
| Balance Sheet | ||||||
| Total Assets | 590M | 524M | 491M | 547M | 636M | 572M |
| Total Liabilities | 25.9M | 21.2M | 53.4M | 54.0M | 70.6M | 75.5M |
| Shareholders' Equity | 546M | 485M | 423M | 482M | 556M | 486M |
| Cash & Short-term Investments | 308M | 224M | 156M | 163M | 188M | 113M |
| Cash Flow | ||||||
| Operating Cash Flow | -52.1M | -57.4M | -48.7M | -77.7M | -91.2M | -88.4M |
| Capital Expenditure | 8.65M | 24.2M | 39.4M | 56.2M | 47.6M | 20.3M |
| Free Cash Flow | -60.8M | -81.6M | -88.1M | -134M | -139M | -109M |
| Ratios | ||||||
| ROE | -15.2% | -13.1% | -15.5% | -19.8% | -26.7% | -29.8% |
| ROA | -14.0% | -12.1% | -13.4% | -17.4% | -23.3% | -25.3% |
| Net Profit Margin | - | -325.7% | -292.4% | -345.5% | -1,416.2% | -336.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NaviFUS Corp. dividends
NaviFUS Corp. has not paid dividends in the last 5 fiscal years.
Who owns NaviFUS Corp.
- Insiders 32.74%
- Institutions 12.39%
- Public & others 54.87%
- Shares outstanding 70.8M
NaviFUS Corp. company profile
- Company name
- NaviFUS Corp.
- Ticker
- 6872.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- No. 246, Chengde Rd., Taipei, Taiwan, 103
- Phone
- 886 2 2586 0560
- Website
- navifus.com
About NaviFUS Corp.
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgical tracking technology to monitor the 3D position of the needle tip during ultrasonic interventional procedures. The company was founded in 2015 and is based in Taipei, Taiwan.
NaviFUS Corp. management
2- Dr. Hao-Li Liu Ph.D.Founder & Chief Technical Consultant
- Dr. Jen Chen Ph.D.Chief Strategy Officer · born 1955